PharmAla Biotech Holdings (OTC:MDXXF) has announced advancement of its contract with UT Health San Antonio for the STRONG STAR Consortium study, ...
News
- PharmAla Develops New MDMA Dosage for $10M DoD-Funded PTSD Study in Military Personnel
- Alzheimer's was taking her memory, so she started taking a new drug - Texas Public Radio
Coach Pop says he will not return to lead the San Antonio Spurs this season ... Bioscience-Medicine · Tablets for tots? Survey says kids watch ...
- Creative BioMart Expands Protein Expression and Purification Services to Support Biotech ...
... San Antonio Spurs coach Gregg Popovich, left, yells at official Josh ... SHIRLEY, NY, UNITED STATES, February 27, 2025 /EINPresswire.com/ -- Creative ...
- Aurinia: Q4 Earnings Snapshot - San Antonio Express-News
The biotechnology company posted revenue of $59.9 million in the period ... Warm temperatures in the upper 70s are expected in San Antonio on ...
- PharmAla to supply STRONG STAR at UT Health San Antonio, with novel dosage form of ...
TORONTO, Feb. 27, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. ... Health San Antonio and director of the STRONG STAR Consortium. The ...